We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$544M
AUM Growth
+$19.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 45.26%
2 Consumer Staples 43.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$238M 43.83%
9,594,816
STAA icon
2
STAAR Surgical
STAA
$1.21B
$117M 21.56%
10,855,179
LCTX icon
3
Lineage Cell Therapeutics
LCTX
$269M
$85.4M 15.71%
30,997,307
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$59.2M 10.88%
420,000
IMDX
5
Insight Molecular Diagnostics
IMDX
$150M
$15.9M 2.92%
152,834
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$14.4M 2.66%
322,411
AST
7
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$13.1M 2.42%
3,699,848
AST.WS
8
DELISTED
Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
$164K 0.03%
328,205

Similar funds

Broadwood Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Broadwood Capital held 8 positions worth $544M, up 3.7% from $524M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Consumer Staples.

  • Broadwood Capital's ten largest holdings make up 100% of its $544M portfolio in Q2 2017.
  • Broadwood Capital opened 0 new positions and closed 0 in Q2 2017.
  • Broadwood Capital's portfolio value rose 3.7% quarter-over-quarter to $544M.

Based on Broadwood Capital's 13F filing for Q2 2017, filed 14 Aug 2017.